Voyager Therapeutics stock trades at 1.76 euros Tuesday

Company: Voyager Therapeutics
ISIN: US92915B1061
Ticker: VYGR
Trading venue: Lang & Schwarz
Quoted trade: 1.76 euros at 13:43 CET on Tuesday, November 10, 2026

Published on 11/10/2026 at 13:51 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS

Voyager Therapeutics stock remains in focus during Tuesday trading. The biotechnology company is active in genetic medicine development.

Tuesday Trading Snapshot

Voyager Therapeutics remains a biotechnology company focused on genetic medicine development.
The latest quoted trade was recorded during Tuesday's Berlin session.

VYGR, US92915B1061, Illustration mit AI erstellt.

Voyager Therapeutics stock traded at 1.76 euros on Lang & Schwarz at 13:43 CET on Tuesday, November 10, 2026. The biotechnology company remains focused on genetic medicines, including programs for neurological disease.

Biotechnology Pipeline In Focus

Voyager Therapeutics develops genetic medicine candidates and has highlighted Alzheimer-related programs in its recent company coverage. For investors, the pipeline and upcoming clinical milestones remain central to the stock's outlook.

The latest trade provides a current reference for the euro quotation during the Berlin session. The next company-specific focus is the scheduled mid-November presentation calendar for Voyager's Alzheimer programs.